News

Oxford Biomedica plc announces that its subsidiary Oxford Biomedica Solutions LLC has signed an agreement with a new undisclosed, U.S. based, private biotechnology company. The…
Read More...

BriaCell Therapeutics Corp. announces that it has signed an agreement with Caris Life Sciences (Caris). “Our goal is to develop immunotherapies that are personalized for each patient,…
Read More...

The U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare Neurodegenerative Diseases (CP-RND) – a…
Read More...

Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living medicines for chronic diseases, announced the close of a $43.5 million Series B financing. The…
Read More...

Novavax, Inc. and Serum Institute of India Pvt. Ltd. (SII) announced that the South African Health Products Regulatory Authority has granted full product registration with conditions…
Read More...

Valeo and the French Alternative Energies and Atomic Energy Commission (CEA) signed an agreement to collaborate on the next generations of power electronics, which are at the heart of…
Read More...

Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, and…
Read More...

RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, announced a $160 million Series D financing co-led by…
Read More...

Syros Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to SY-5609 for the treatment of pancreatic cancer.…
Read More...

Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced expansion of its clinical collaboration with Pfizer in…
Read More...

InnoCare Pharma announced that the Company has received Investigational New Drug (IND) approval of clinical trial from the NMPA (National Medical Products Administration) for its B-cell…
Read More...

A UNIQUE WORKFLOW SOLUTION INTEGRATING A PAN-CANCER NEXT-GENERATION SEQUENCING (NGS) PANEL POWERED BY A BIOINFORMATICS SOFTWARE SUITE FOR CUSTOMIZABLE BIOLOGICAL AND CLINICAL…
Read More...

AmerisourceBergen Corporation announced that it has signed a definitive agreement to acquire PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences…
Read More...

Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug…
Read More...

Novartis announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will bolster its capacity…
Read More...

Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders,  announced the closing of a $32.7 million financing to support the…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Sotyktu (deucravacitinib), a first-in-class, oral, selective, allosteric tyrosine kinase 2…
Read More...

Gatehouse Bio, a pioneer in small RNA therapeutics, and AstraZeneca, a global, science-led biopharmaceutical company, are advancing their partnership, to create RNA therapeutics for the…
Read More...

Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, announced that the U.S. Food and Drug…
Read More...

Pfizer Inc. announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designation from the U.S. Food and Drug…
Read More...